A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS

Area of Science:

• Forensic Chemistry
• Analytical Chemistry
• Toxicology

Background:

• Synthetic cannabinoids (SCs) are potent psychoactive substances designed to mimic Δ9-tetrahydrocannabinol.
• The emergence of novel SCs, such as PINACA and FUBINACA derivatives, poses challenges for drug detection due to their illicit market prevalence.
• Regulatory controls on common cannabinoids have driven the development of new synthetic variants.

Purpose of the Study:

• To develop and validate a robust analytical method for detecting 32 synthetic cannabinoid metabolites in human urine.
• To incorporate metabolites from new-generation synthetic cannabinoids into the analytical scope.
• To provide a reliable tool for forensic and clinical toxicology laboratories.

Main Methods:

• Urine samples underwent enzymatic hydrolysis followed by liquid-liquid extraction using a 1-chlorobutane:isopropyl alcohol solvent system.
• Chromatographic separation was performed on an Agilent 1290 liquid chromatograph.
• Detection and quantification were achieved using an Agilent 6460 triple quadrupole mass spectrometer equipped with a Jetstream electrospray source.

Main Results:

• The method demonstrated linearity from 0.5-200 ng/mL for all analytes.
• Accuracy and precision were within acceptable limits (±20% error, ±15% RSD), with analyte recovery ranging from 48% to 104%.
• The validated method successfully detected 11 distinct synthetic cannabinoids in 23 out of 25 analyzed urine samples, showing high selectivity and specificity.

Conclusions:

• A validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method provides accurate identification and quantification of synthetic cannabinoid metabolites in urine.
• The method effectively incorporates new-generation synthetic cannabinoid derivatives, addressing a critical need in drug monitoring.
• This validated assay is suitable for routine toxicological analysis, aiding in the identification of synthetic cannabinoid use.